GemVax & KAEL Co Ltd
KOSDAQ:082270
Intrinsic Value
The intrinsic value of one GemVax & KAEL Co Ltd stock under the Base Case scenario is 2 597.99 KRW. Compared to the current market price of 35 500 KRW, GemVax & KAEL Co Ltd is Overvalued by 93%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
GemVax & KAEL Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
GemVax & KAEL Co Ltd
Balance Sheet Decomposition
GemVax & KAEL Co Ltd
Current Assets | 25.2B |
Cash & Short-Term Investments | 3.6B |
Receivables | 11.1B |
Other Current Assets | 10.5B |
Non-Current Assets | 125.6B |
Long-Term Investments | 55.3B |
PP&E | 36.6B |
Intangibles | 3.3B |
Other Non-Current Assets | 30.4B |
Free Cash Flow Analysis
GemVax & KAEL Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
GemVax & KAEL Co Ltd
Revenue
|
62.7B
KRW
|
Cost of Revenue
|
-43B
KRW
|
Gross Profit
|
19.7B
KRW
|
Operating Expenses
|
-58.1B
KRW
|
Operating Income
|
-38.3B
KRW
|
Other Expenses
|
-48.9B
KRW
|
Net Income
|
-87.2B
KRW
|
Profitability Score
Profitability Due Diligence
GemVax & KAEL Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
GemVax & KAEL Co Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
GemVax & KAEL Co Ltd's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Score
GemVax & KAEL Co Ltd's solvency score is 18/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
GemVax & KAEL Co Ltd
Dividends
Current shareholder yield for GemVax & KAEL Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one GemVax & KAEL Co Ltd stock under the Base Case scenario is 2 597.99 KRW.
Compared to the current market price of 35 500 KRW, GemVax & KAEL Co Ltd is Overvalued by 93%.